top of page

Evaluation of the Liver Multiscan MRI for NASH (CATE-NASH)

Aim: To evaluate the Liver Multiscan as an alternative to liver biopsy in NAFLD and NASH 

HIV-NASH AIM 1 Trial

Aim: To determine the prevalence of NAFLD or NASH in persons living with HIV

Tissue Repository for the Study of NAFLD

Aim: To understand the risk factors for progressive liver disease and cardiometabolic complications of NAFLD, and to identify non-invasive biomarkers for NASH and fibrosis

Intra-Hepatic Immune Signature in NAFLD

Aim: To identify immune cell subsets with pathogenic and/or protective functions in relation to inflammation and fibrosis in the liver in the context of NASH 

Fine Needle Aspiration Biopsy (FNAB)-NASH

Aim: To study single cell transcriptome profile of liver fine needle aspirations (FNAB) derived macrophages

Intermittent Fasting for the Treatment of NAFLD

Aim: A 6 week study of intermittent fasting for the treatment of NAFLD

Aldafermin for the Treatment of NASH Cirrhosis

Aim: To evaluate the efficacy of GHRH for the treatment of NASH, fibrosis and cardiovascular risk

bottom of page